Prescription-event: Monitoring-recent progress and future horizons

British Journal of Clinical Pharmacology

Volumn 46, Issue 3, 1998, Pages 195-201

  Mann, R D ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

Cohort studies; Drug safety monitoring; Pharmacoepidemiology; Pharmacovigilance; Prescription event monitoring

Indexed keywords

ACARBOSE; ACICLOVIR; ALENDRONIC ACID; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; BAMBUTEROL; BETAXOLOL; BUSPIRONE; CEPHALOSPORIN; DILTIAZEM; ENOXACIN; ETODOLAC; FAMOTIDINE; ISRADIPINE; LANSOPRAZOLE; LORATADINE; LOSARTAN; MISOPROSTOL; MOCLOBEMIDE; NEDOCROMIL; PAROXETINE; PERINDOPRIL; PROSTAGLANDIN; PROTON PUMP INHIBITOR; TERODILINE; UNINDEXED DRUG; XAMOTEROL;

COHORT ANALYSIS; CONVULSION; DATA BASE; DIARRHEA; DRUG MARKETING; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; DYSPEPSIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RASH; SHORT SURVEY; SIDE EFFECT; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG MONITORING; FEMALE; FORECASTING; GREAT BRITAIN; HUMANS; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PRESCRIPTIONS, DRUG; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0031696868     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00774.x     Document Type: Short Survey

References (17)

1. Rawlins MD, Jefferys DB. Study of United Kingdom product licence applications containing new active substances, 1987-9. Br Med J 1991; 302: 223-225.
2. Committee on Safety of Drugs. Report for 1969 and 1970. London, HMSO, 1971.
3. Mann RD. The yellow card data: the nature and scale of the adverse drug reactions problems. In Adverse drug reactions. ed. Mann RD Carnforth, UK; Parthenon Publishing. 1987, 62-63.
4. Freemantle SN, Pearce GL, Wilton LV, Mackay FJ, Mann RD. The incidence of the most commonly reported events with 40newly marketed drugs - a study by Prescription-Event Monitoring. Pharmacoepidemiology and Drug Safety 1997; 6: 1.
5. British Medical Association. Reporting Adverse Drug Reactions. A BMA policy document. British Medical Association. London. 1996.
6. Mann RD, Wilton LV, Pearce GL, Mackay FJ, Dunn NR. Prescription-Event Monitoring (PEM) in 1996 - a method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiology and Drug Safety 1997; 6: Suppl.3: S5-S11.
7. Wilton LV, Mackay F, Pearce G, Mann RD. The outcomes of pregnancy in women prescribed newly marketed drugs in 34 studies conducted by Prescription-Event Monitoring (PEM). Pharmacoepidemiology and Drug Safety 1997; 6: Abstract 072.
8. Wilton L, Pearce G, Edet E, Freemantle S, Stephens MDB and Mann RD. The safety of finasteride used in benign prostatic hypertrophy a non-interventional observational cohort study in 14 772 patients. Br J Urology 1996; 78: 379-384.
9. Stephens MDB, Wilton LV, Pearce G, Mann RD. Visual field defects in patients taking vigabatrin. Pharmacoepidemiology and Drug Safety. 1997; 6: Suppl.2: Abstract 041.
10. Dunn N, Wilton LV, Pearce G, Mann RD. The incidence of hallucinations associated with tramadol. Pharmacoepidemiology and Drug Safety 1997; 6; Suppl.2: Abstract 042.
11. Mackay F, Wilton LV, Pearce G, Freemantle S, Mann RD. Acarbose and gastrointestinal intolerance. Pharmacoepidemiology and Drug Safety 1997; 6: Suppl.2: Abstract 044.
12. Mackay F, Wilton LV, Pearce G, Freemantle S, Mann RD. Alendronate and oesophageal reactions. Pharmacoepidemiology and Drug Safety 1997; 6: Suppl.2: Abstract 045.
13. Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD. Safety of long-term lamotrigine in epilepsy. Epilepsia 38: 881-886.
14. Eke T, Talbot JF, Lawden MC. Severe persistent visual field construction associated with vigabatrin. Br Med J 1997; 314: 180-181.
15. Wilton LV, Freemantle S, Martin RM, Mann RD. Is the incidence of upper respiratory infections independent of drug treatment in large cohort studies? Proceedings of the European Society of Pharmacovigilance, Berlin 1997. Pharmacoepidemiology and Drug Safety (in press).
16. Dunn NR, Thorogood M, deCaestecker L, Mann RD. Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study). Pharmacoepidemiology and Drug Safety 1997; 6: 283-289.
17. Mackay F. Postmarketing Studies: the value of the work of the Drug Safety Research Unit. Drug Safety 1998 (in press).